| Alterations of the brain reward system in antipsychotic naïve schizophrenia patients MØ Nielsen, E Rostrup, S Wulff, N Bak, H Lublin, S Kapur, B Glenthøj Biological psychiatry 71 (10), 898-905, 2012 | 229 | 2012 |
| Improvement of brain reward abnormalities by antipsychotic monotherapy in schizophrenia MO Nielsen, E Rostrup, S Wulff, N Bak, BV Broberg, H Lublin, S Kapur, ... Archives of general psychiatry 69 (12), 1195-1204, 2012 | 168 | 2012 |
| Glucagon‐like peptide‐1 receptor agonists for antipsychotic‐associated cardio‐metabolic risk factors: A systematic review and individual participant data meta‐analysis D Siskind, M Hahn, CU Correll, A Fink‐Jensen, AW Russell, N Bak, ... Diabetes, Obesity and Metabolism 21 (2), 293-302, 2019 | 101 | 2019 |
| Source localization of sensory gating: a combined EEG and fMRI study in healthy volunteers N Bak, BY Glenthoj, E Rostrup, HB Larsson, B Oranje Neuroimage 54 (4), 2711-2718, 2011 | 76 | 2011 |
| Effect of GLP‐1 receptor agonist treatment on body weight in obese antipsychotic‐treated patients with schizophrenia: a randomized, placebo‐controlled trial PL Ishøy, FK Knop, BV Broberg, N Bak, UB Andersen, NR Jørgensen, ... Diabetes, Obesity and Metabolism 19 (2), 162-171, 2017 | 66 | 2017 |
| Social cognition in patients at ultra-high risk for psychosis: what is the relation to social skills and functioning? LB Glenthøj, B Fagerlund, C Hjorthøj, JRM Jepsen, N Bak, TD Kristensen, ... Schizophrenia Research: Cognition 5, 21-27, 2016 | 65 | 2016 |
| Striatal D2/3 Binding Potential Values in Drug-Naïve First-Episode Schizophrenia Patients Correlate With Treatment Outcome S Wulff, LH Pinborg, C Svarer, LT Jensen, MØ Nielsen, P Allerup, N Bak, ... Schizophrenia bulletin 41 (5), 1143-1152, 2015 | 46 | 2015 |
| Two subgroups of antipsychotic-naive, first-episode schizophrenia patients identified with a Gaussian mixture model on cognition and electrophysiology N Bak, BH Ebdrup, B Oranje, B Fagerlund, MH Jensen, SW Düring, ... Translational psychiatry 7 (4), e1087-e1087, 2017 | 44 | 2017 |
| Concurrent functional magnetic resonance imaging and electroencephalography assessment of sensory gating in schizophrenia N Bak, E Rostrup, HBW Larsson, BY Glenthøj, B Oranje Human brain mapping 35 (8), 3578-3587, 2014 | 44 | 2014 |
| Negative symptoms mediate the relationship between neurocognition and function in individuals at ultrahigh risk for psychosis LB Glenthøj, JRM Jepsen, C Hjorthøj, N Bak, TD Kristensen, ... Acta Psychiatrica Scandinavica 135 (3), 250-258, 2017 | 38 | 2017 |
| No cognitive‐enhancing effect of GLP‐1 receptor agonism in antipsychotic‐treated, obese patients with schizophrenia PL Ishøy, B Fagerlund, BV Broberg, N Bak, FK Knop, BY Glenthøj, ... Acta Psychiatrica Scandinavica 136 (1), 52-62, 2017 | 36 | 2017 |
| A machine-learning framework for robust and reliable prediction of short-and long-term treatment response in initially antipsychotic-naïve schizophrenia patients based on … KS Ambrosen, MW Skjerbæk, J Foldager, MC Axelsen, N Bak, ... Translational psychiatry 10 (1), 276, 2020 | 30 | 2020 |
| Deficient prepulse inhibition of the startle reflex in schizophrenia using a cross-modal paradigm K Haß, N Bak, GR Szycik, BY Glenthøj, B Oranje Biological Psychology 128, 112-116, 2017 | 28 | 2017 |
| Accuracy of diagnostic classification algorithms using cognitive-, electrophysiological-, and neuroanatomical data in antipsychotic-naïve schizophrenia patients BH Ebdrup, MC Axelsen, N Bak, B Fagerlund, B Oranje, JM Raghava, ... Psychological medicine 49 (16), 2754-2763, 2019 | 25 | 2019 |
| Cortical structures and their clinical correlates in antipsychotic-naïve schizophrenia patients before and after 6 weeks of dopamine D2/3 receptor antagonist treatment K Jessen, E Rostrup, RCW Mandl, MØ Nielsen, N Bak, B Fagerlund, ... Psychological Medicine 49 (5), 754-763, 2019 | 20 | 2019 |
| Sexual dysfunction and hyperprolactinemia in schizophrenia before and after six weeks of D2/3 receptor blockade–An exploratory study SW Düring, MØ Nielsen, N Bak, BY Glenthøj, BH Ebdrup Psychiatry Research 274, 58-65, 2019 | 15 | 2019 |
| The impact of schizophrenia and intelligence on the relationship between age and brain volume MH Jensen, N Bak, E Rostrup, MØ Nielsen, C Pantelis, BY Glenthøj, ... Schizophrenia Research: Cognition 15, 1-6, 2019 | 13 | 2019 |
| Bone status in obese, non-diabetic, antipsychotic-treated patients, and effects of the glucagon-like peptide-1 receptor agonist exenatide on bone turnover markers and bone … R Eriksson, BV Broberg, PL Ishøy, N Bak, UB Andersen, NR Jørgensen, ... Frontiers in Psychiatry 9, 781, 2019 | 13 | 2019 |
| Rasch analysis of the PANSS negative subscale and exploration of negative symptom trajectories in first-episode schizophrenia–data from the OPTiMiSE trial L Baandrup, P Allerup, MØ Nielsen, N Bak, SW Düring, S Leucht, ... Psychiatry Research 289, 112970, 2020 | 11 | 2020 |
| Attenuated mismatch negativity in patients with first-episode antipsychotic-naive schizophrenia using a source-resolved method M Randau, B Oranje, M Miyakoshi, S Makeig, B Fagerlund, B Glenthøj, ... NeuroImage: Clinical 22, 101760, 2019 | 11 | 2019 |
Bjørn H. EbdrupProfessor, Consultant Psychiatrist, Centre for Neuropsychiatric Schizophrenia Research, CNSRDirección de correo verificada de cnsr.dk
